FDA Approves Alsuma
FDA Approves Alsuma Auto-Injector
June 29, 2010 -- The United States Food and Drug Administration (FDA) has approved Alsuma (sumatriptan injection) Auto-Injector for the acute treatment of migraine attacks, with or without aura. Alsuma is also indicated for the acute treatment of cluster headache episodes.
Alsuma is manufactured by Meridian Medical Technologies, Inc., a wholly-owned subsidiary of King Pharmaceuticals, Inc.
Posted: July 2010
Alsuma (sumatriptan) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
